Oral NSAIDs (e.g., Ibuprofen, Naproxen)

Treatment for Osteoarthritis

Typical Dosage: Ibuprofen 200-800mg 3x daily, Naproxen 250-500mg 2x daily

Effectiveness
75%
Safety Score
75%
Clinical Trials
1,500
Participants
300K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
75
DangerousModerateSafe
Treatment Details
Dosage Range
Ibuprofen 200-800mg 3x daily, Naproxen 250-500mg 2x daily
Time to Effect
Immediate to 1-2 days
Treatment Duration
As needed or daily for chronic pain
Evidence Quality
HIGH
Number Needed to Treat (NNT)
4(Treat 4 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
150(Treat 150 patients to see 1 additional serious adverse event)
Confidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$75
Monitoring:$100
Side Effect Mgmt:$200
Total Annual:$375
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
ICER
$20,000/QALY
QALYs Gained
0.08
Outcome-Based Costs
Cost per Responder
$577
Comparison vs Acetaminophen
Cost Difference
+$50/year
More expensive
QALY Difference
+0.02 QALYs
Better outcomes
Dominance
No dominance
Oral NSAIDs (e.g., Ibuprofen, Naproxen) Outcomes

for Osteoarthritis

Efficacy Outcomes
Overall Effectiveness
+75%
Response Rate
+65%
Common Side Effects
GI upset (nausea, heartburn)
+15%
GI bleed/ulcer
+3%
Increased blood pressure
+7%
Kidney dysfunction
+3%
Cardiovascular events
+0.75%

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov